Allopurinol

Zyloprim

Strengths & Sizes

Allopurinol
Allopurinol

Note: product and packaging images are not actual size

  • NDC#31722-252-01
  • UPC Code331722252010
  • ImprintU5 | H
Allopurinol
Allopurinol

Note: product and packaging images are not actual size

  • NDC#31722-252-05
  • UPC Code331722252058
  • ImprintU5 | H
Allopurinol
Allopurinol

Note: product and packaging images are not actual size

  • NDC#31722-252-10
  • UPC Code331722252102
  • ImprintU5 | H
Allopurinol
Allopurinol

Note: product and packaging images are not actual size

  • NDC#31722-253-01
  • UPC Code331722253017
  • ImprintU6 | H
Allopurinol
Allopurinol

Note: product and packaging images are not actual size

  • NDC#31722-253-05
  • UPC Code331722253055
  • ImprintU6 | H
Allopurinol
Allopurinol

Note: product and packaging images are not actual size

  • NDC#31722-253-10
  • UPC Code331722253109
  • ImprintU6 | H

Indications

Allopurinol tablets is a xanthine oxidase inhibitor indicated for the management of: - Adult patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy) - Adult and pediatric patients with leukemia, lymphoma and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels - Adult patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients, despite lifestyle changes